BELZUPACAP SAROTALOCAN

UNII:	DK0ZGA5Y2R
Formula:
Preferred Substance Name:	BELZUPACAP SAROTALOCAN
GSRS Full Record:	DK0ZGA5Y2R i

2390462-37-8
AU011
AU-011
BELZUPACAP SAROTALOCAN [INN]
BELZUPACAP SAROTALOCAN [USAN]
BELZUPACAP SAROTALOCAN [WHO-DD]
CAPSOMERE, (273-THREONINE, 285-THREONINE, 288-ASPARAGINE) HUMAN PAPILLOMAVIRUS 16 MAJOR CAPSID PROTEIN L1, PENTAMER, COMPLEX WITH MINOR CAPSID PROTEIN L2, DOHEPTACONTAMER, DICTAKIS(N6-(1-OXO-6-(((3-((29H,31H-PHTHALOCYANIN-1-YL- .KAPPA.N29,.KAPPA.N30,.KAPPA.N31,.KAPPA.N32)OXY)PROPOXY)CARBONYL)AMINO)HEXYL)-L-LYSINE, COMPLEX WITH BIS((DIMETHYL(3-(TRIS(3-SULFOPROPYL)AMMONIO)PROPYL)SILYL)OXY)SILICONE, BIS(INNER SALT), SODIUM SALT (1:4))
HPV-NP AU-011
HUMAN PAPILLOMAVIRUS VIRUS-LIKE PARTICLES CONJUGATED WITH IR700 DYE AU-011
LIGHT-ACTIVATED AU-011
VIRAL NANOPARTICLE CONJUGATES AU-011
VNC AU-011

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

BELZUPACAP SAROTALOCAN

Synonyms and Mappings

Resources